Natixis’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Natixis's JNJ Position: Q2 2026 in Review
Natixis increased its Johnson & Johnson (JNJ) stake by 231% in Q2 2026, buying an estimated $115M and bringing the position to 707,790 shares worth $180M. The position accounts for 0.72% of the portfolio, ranked #21.
Natixis first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $355M in Q3 2017. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Natixis held 707,790 shares of Johnson & Johnson worth $180M as of Q2 2026.
- Natixis bought 493,965 Johnson & Johnson shares in Q2 2026, an estimated $115M.
- Johnson & Johnson made up 0.72% of Natixis's portfolio in Q2 2026, its #21 holding.
- Natixis first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
- Natixis's Johnson & Johnson position peaked at $355M in Q3 2017.
- 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.